Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caries prevention describes the multifaceted effort to avoid the initiation and progression of dental caries (tooth decay). This is not a single molecular or protein target, but encompasses a variety of preventive measures—such as fluoride application, antibacterial agents, nanoparticles, and small-molecule inhibitors—that disrupt biofilm formation, prevent demineralization of tooth enamel, or inhibit bacterial virulence mechanisms, especially in Streptococcus mutans. Advances in materials like nanoparticles, bioactive hydrogels, and targeting bacterial enzymes such as matrix metalloproteinase-3 are expanding options for caries risk reduction. Most current therapies focus on modifying microbial composition, reducing acid production, and reinforcing enamel[1][2][3][4][5].
Inhibition of enamel demineralization (fluoride); Disruption of biofilm formation (e.g. small-molecule inhibitors target S. mutans biofilm synthesis)[2]; Antibacterial activity (antimicrobials/nanoparticles)[1][2]; Inhibition of matrix metalloproteinase-3 to reduce dentin matrix degradation[4]
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caries prevention.